Disease-modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta-analysis.

Valizadeh, Amir; Fattahi, Mohammad Reza; Sadeghi, Maryam; Saghab Torbati, Mehrnush; Sahraian, Mohammad Ali; Azimi, Amir Reza

Valizadeh, Amir; Fattahi, Mohammad Reza; Sadeghi, Maryam; Saghab Torbati, Mehrnush; Sahraian, Mohammad Ali; Azimi, Amir Reza.

Afiliación

Valizadeh A; Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Fattahi MR; Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sadeghi M; Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Saghab Torbati M; Islamic Azad University of Zahedan, Zahedan, Iran.
Sahraian MA; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Azimi AR; Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.

CNS Neurosci Ther ; 28(5): 648-657, 2022 05.

Article en En | MEDLINE | ID: mdl-35218155

Asunto(s)

Esclerosis Múltiple Recurrente-Remitente; Esclerosis Múltiple; Adulto; Humanos; Inmunosupresores/efectos adversos; Esclerosis Múltiple/tratamiento farmacológico

Palabras clave

alemtuzumab; cladribine; dimethyl fumarate; fingolimod; glatiramer acetate; interferon beta-1a; magnetic resonance imaging; multiple sclerosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Esclerosis Múltiple Tipo de estudio: Prognostic_studies / Systematic_reviews Límite: Adult / Humans Idioma: En Revista: CNS Neurosci Ther Asunto de la revista: NEUROLOGIA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google